Michael Geißler

Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer

Emmanouil Fokas, Anke Schlenska‐Lange, Bülent Polat et al. · JAMA Oncology · 2021 · 354 citations · Full text

Medicine, Surgery, Gastrointestinal Oncology +13

Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer

Alexandros Papachristofilou, M. Hipp, Ute Klinkhardt et al. · Journal for ImmunoTherapy of Cancer · 2019 · 222 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Cetuximab with irinotecan, folinic acid and 5-fluorouracil as first-line treatment in advanced gastroesophageal cancer: a prospective multi-center biomarker-oriented phase II study

Markus Moehler, Annett Mueller, Tanja Trarbach et al. · Annals of Oncology · 2010 · 126 citations · Full text

Medicine, Oncology, Pharmacology +16

Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findings

Stefan Kubicka, Richard Greil, Thierry André et al. · Annals of Oncology · 2013 · 103 citations · Full text

Medicine, Oncology, Pharmacotherapy +9

Capecitabine/irinotecan or capecitabine/oxaliplatin in combination with bevacizumab is effective and safe as first-line therapy for metastatic colorectal cancer: a randomized phase II study of the AIO colorectal study group

Wolff Schmiegel, A. Reinacher-Schick, Dirk Arnold et al. · Annals of Oncology · 2013 · 73 citations

Medicine, Oncology, Pharmacology +13